Xiaoliang J. Liu
71 Xinmin Street
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Journal: Frontiers in immunology
Published: April 30, 2025
Combination of metagenomic next-generation sequencing and conventional tests unraveled pathogen profiles in infected patients undergoing allogeneic hematopoietic stem cell transplantation in Jilin Province of China.
Journal: Frontiers in cellular and infection microbiology
Published: January 29, 2024
Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes.
Journal: Annals of hematology
Published: June 01, 2023
Therapeutic potential of engineering the mitochondrial genome.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 20, 2023
CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations.
Journal: Annals of hematology
Published: February 02, 2019
Clinical analysis of 16 children with traumatic basal ganglia stroke
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: January 12, 2019
Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.
Journal: Reviews in the neurosciences
Published: September 12, 2018
Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantation.
Journal: Bone marrow transplantation
Published: August 10, 2018
Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance.
Journal: Oncotarget
Published: March 16, 2017
Targeted breast cancer therapy by harnessing the inherent blood group antigen immune system.
Journal: Oncotarget
Published: September 26, 2016
Last Updated: 09/26/2026